FSD Pharma Receives FDA Approval to Design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis Read more
PharmAbcine signs a license agreement with Wincal Biopharm to expand indications of PharmAbcine’s existing assets to non-oncology areas Read more
Bristol Myers Squibb announces positive topline results from True North trial evaluating Zeposia in ulcerative colitis Read more
Codiak BioSciences Collaborates with Ragon Institute to Evaluate the exoVACC Vaccine Platform in SARS-CoV-2 and HIV Read more
AVEO Oncology announces FDA acceptance for filing of an NDA for Tivozanib as treatment of relapsed or refractory renal cell carcinoma Read more